Israeli Medical Cannabis Company InterCure Sees Q4 Revenue T

InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue – 3 Times YoY and 24% QoQ Growth. Estimated revenue reaches over CAD$31 million (a record NIS 77 million)... #Canndoc #INCR #INCRU

Related Keywords

Austria , United States , Herzliya , Tel Aviv , Israel , Canada , United Kingdom , Toronto , Ontario , America , Israeli , Canadian , Canndoc Intercure , Alexander Rabinovitch , Intercure Ltd , Nasdaq , Intercure Reports Record Preliminary , Quarter Revenue , New Israeli Shekels , Fourth Quarter , Chief Executive Officer , Good Manufacturing Practices , New Cannabis Ventures ,